Abstract
During the early phase of senile degeneration of the macula treatment with Cosaldon A + E offers real changes of improvement. In the later phases long-term Cosaldon therapy can bring about an appreciable improvement when other vasoactive substances are administered at intervals. The addition of the vitamins A and E improves the efficacy of Cosaldon. Results in 157 patients are supported by statistics.

This publication has 0 references indexed in Scilit: